21 results
424B3
PYXS
Pyxis Oncology Inc
30 Jun 23
Prospectus supplement
4:05pm
and expenses Apexigen may incur due to injuries to Apexigen’s employees resulting from the use of hazardous materials, this insurance may not provide
S-4/A
ugg39bnlg
29 Jun 23
Registration of securities issued in business combination transactions (amended)
4:09pm
S-4
sle3rhqavdg 6imu
8 Jun 23
Registration of securities issued in business combination transactions
8:03am
10-K
4c3n2gl mqk535t
29 Mar 22
Annual report
7:36am
10-Q
8yyo6dq0sgy pr
15 Nov 21
Quarterly report
7:54am
424B4
ho5dd bjtkc
8 Oct 21
Prospectus supplement with pricing info
5:00pm
S-1/A
EX-10.15
0j0 4ztualg2jtgq
30 Sep 21
IPO registration (amended)
9:11pm
S-1
2pu 819plof1
17 Sep 21
IPO registration
5:00pm
DRS/A
35x3qmn m1o
10 Sep 21
Draft registration statement (amended)
12:00am
DRS/A
elxag4s
4 Aug 21
Draft registration statement (amended)
12:00am